| SAINT LAURENT, Quebec, Dec. 21, 2011 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCBB:IGXT) ("IntelGenx") today announced that it has entered into a co-development and commercialization agreement with Par Pharmaceutical, Inc. ("Par") for a new product utilizing one of IntelGenx' proprietary oral drug delivery platforms. Product description and financial terms were not disclosed. Under the terms of the agreement, Par has obtained certain exclusive rights to market and sell IntelGenx' product i...continued IGX:CA IGXT shares pharmaceuticals Services |
Wednesday, December 21, 2011
IntelGenx Announces Development and Commercialization Agreement With Par Pharmaceutical, Inc.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment